Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.17 USD | -3.97% | -9.83% | +2.29% |
May. 13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
May. 10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SOLENO THERAPEUTICS, INC. | Bio Therapeutic Drugs | -3.97% | -9.83% | +2.29% | +662.41% | +28.26% | 1.56B |
Technical Rankings Surperformance
- Stock Market
- Equities
- SLNO Stock
- Charts Soleno Therapeutics, Inc.
- Comparison Chart